These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29416441)

  • 1. C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells.
    Jiang L; Wang Y; Liu G; Liu H; Zhu F; Ji H; Li B
    Cancer Cell Int; 2018; 18():12. PubMed ID: 29416441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells.
    Ravi M; Tentu S; Baskar G; Rohan Prasad S; Raghavan S; Jayaprakash P; Jeyakanthan J; Rayala SK; Venkatraman G
    BMC Cancer; 2015 Oct; 15():768. PubMed ID: 26499490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells.
    Ji H; Liu G; Han J; Zhu F; Dong X; Li B
    Cancer Cell Int; 2020; 20():292. PubMed ID: 32655324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavopereirine induces cell cycle arrest and apoptosis via the AKT/p38 MAPK/ERK1/2 signaling pathway in human breast cancer cells.
    Yeh HT; Tsai YS; Chen MS; Li YZ; Lin WC; Lee YR; Tseng YS; Sheu SM
    Eur J Pharmacol; 2019 Nov; 863():172658. PubMed ID: 31518562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
    Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
    Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phycocyanin Inhibits Tumorigenic Potential of Pancreatic Cancer Cells: Role of Apoptosis and Autophagy.
    Liao G; Gao B; Gao Y; Yang X; Cheng X; Ou Y
    Sci Rep; 2016 Oct; 6():34564. PubMed ID: 27694919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase/p21/p27 axis.
    Lee HL; Lin CS; Kao SH; Chou MC
    Anticancer Drugs; 2017 Nov; 28(10):1150-1156. PubMed ID: 28938245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphtho[1,2-b]furan-4,5-dione induces apoptosis and S-phase arrest of MDA-MB-231 cells through JNK and ERK signaling activation.
    Lin KL; Su JC; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2010 Feb; 24(1):61-70. PubMed ID: 19747539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways.
    Montazersaheb S; Farahzadi R; Fathi E; Alizadeh M; Abdolalizadeh Amir S; Khodaei Ardakan A; Jafari S
    Heliyon; 2024 Mar; 10(5):e26959. PubMed ID: 38455550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
    Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
    Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
    Li G; Yang M; Zuo L; Wang MX
    Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
    Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
    Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells.
    Hu X; Washington S; Verderame MF; Manni A
    Cancer Res; 2005 Dec; 65(23):11026-33. PubMed ID: 16322252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
    Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
    Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dioscin Decreases Breast Cancer Stem-like Cell Proliferation via Cell Cycle Arrest by Modulating p38 Mitogen-activated Protein Kinase and AKT/mTOR Signaling Pathways.
    Chae WO; Kim GD
    J Cancer Prev; 2021 Sep; 26(3):183-194. PubMed ID: 34703821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.